Robot-assisted ultrasound biopsy of the prostate
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a robot-assisted method to take prostate tissue samples using an ultrasound probe placed through the rectum. It may help patients and doctors get clearer biopsy results when there are early warning signs of prostate problems, before a cancer diagnosis is confirmed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for your first diagnostic prostate biopsy
- You have a concerning PSA blood test (PSA above 4) and/or a concerning rectal exam result
- You have NOT already been diagnosed with prostate cancer
- You have NOT had a prostate biopsy before
- You do not have anal narrowing that blocks the ultrasound probe
- Your bowel prep is adequate for the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new imaging technique (PSMA-PET/MRI fused with ultrasound) helps surgeons perform more precise robotic prostate removal in men with prostate cancer that has started to spread outside the gland. It aims to improve cancer control and reduce side effects.
This trial tests a computer model that learns from MRI scans to predict prostate cancer. If you have had a prostate MRI showing suspicious areas and are scheduled for a biopsy, joining may help improve how cancer is detected.
This trial tests a new way to rebuild the urethra during robot-assisted prostate removal surgery for prostate cancer. It may help people whose cancer hasn't spread too far or has been reduced enough for surgery.
This trial is testing a new way to do prostate biopsies by combining MRI findings with a targeted biopsy on the same side as the suspicious area. It is for men who have not had a biopsy before and have a moderately high PSA level.
This study tests a new way to guide prostate biopsies using a special scan (PSMA PET/CT) that highlights suspicious areas. If you need a biopsy because of high PSA and abnormal MRI, this approach might help make the biopsy more accurate.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.